BioSpace News Archive

Business

CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19

To date, 10 plasma companies globally have joined the CoVIg-19 Plasma Alliance, founded to accelerate development of a plasma-derived hyperimmune globulin therapy against COVID-19.

May 8, 2020
·
2 min read
·
Mark Terry
Pharm Country

Large Study Suggests Malaria Drug Hydroxychloroquine Doesn’t Help COVID-19

The research was published in the New England Journal of Medicine on Thursday, May 7.

May 8, 2020
·
3 min read
·
Mark Terry
Business

Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

The partnership is aimed at creating antibody products that could act as a “protective shield” against infection by the virus that causes COVID-19, SARS-CoV-2.

May 8, 2020
·
3 min read
·
Mark Terry
Drug Development

Biopharma Update on the Novel Coronavirus: May 8

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.

May 8, 2020
·
5 min read
·
BioSpace Editorial Staff
Business

Distribution of Moderna’s COVID-19 Vaccine Supply Will Be Limited at First, CEO Says

One day after Moderna announced its COVID-19 vaccine candidate has moved into Phase II testing, Chief Executive Officer Stéphane Bancel laid out the bad news – if it works, there won’t be enough of the vaccine to be quickly distributed across the globe.

May 8, 2020
·
2 min read
·
Alex Keown
Pharm Country

Study: Anticoagulants May Be Key to Preventing Clots in COVID-19 Patients

A study published by researchers from The Mount Sinai Hospital/Mount Sinai School of Medicine on May 6 revealed that blood thinners may slow down clotting in patients with COVID-19, ultimately improving their chances of survival.

May 8, 2020
·
2 min read
·
Krystle Vermes
Research Paper Stresses Importance of Repurposing Drugs Against COVID-19

While it may be quicker than developing a vaccine, finding the right drugs to treat the disease will still be tricky.

May 8, 2020
·
2 min read
·
Alex Keown
BioForest

Clinical Catch-Up: May 4-8

It’s the first time in several weeks that the number of non-COVID-19-related clinical trial stories outnumber the COVID-19-related stories. It’s also a hopeful sign that some of the rest of the clinical trials are getting back on track. Here’s a look.

May 8, 2020
·
10 min read
·
Mark Terry
Business

AMO Drug May Restore Normal Learning Function in Some Genetic Brain Diseases

AMO Pharma, a British biopharmaceutical company, is targeting a pathway most often associated with cancer to treat people with genetic encephalopathy.

May 8, 2020
·
4 min read
·
Gail Dutton
FDA

FDA Grants Emergency Use Authorization for Rutgers’ At-Home COVID-19 Saliva Test

The new at-home saliva self-collection assay allows for broader screening than the standard and uncomfortable method using nose and throat swabs at a healthcare facility or testing location that requires a physical interaction with a healthcare professional.

May 8, 2020
·
2 min read
·
Alex Keown